Jesus Berdeja, MD on CAR-T Therapy JNJ-4528 @SarahCannonDocs #ASCO2020 #ASCO

Jesus Berdeja, MD of Sarah Cannon Research Institute discusses the CAR-T therapy JNJ-4528 in pretreated patients with multiple myeloma.

Read here: https://meetinglibrary.asco.org/record/186155/abstract